HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, M. Articles by Engel, A. G. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, M. Articles by Engel, A. G.

Mitochondrial DNA deletions in mitochondrial cytopathies

Observations in 19 patients

Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN.

Among 56 patients with mitochondrial myopathies or cytopathies, 19 had large-scale deletions of mitochondrial DNA (mtDNA). Consistent with previous observations, all 19 had progressive external ophthalmoplegia and 12 had complete or partial Kearns-Sayre syndrome. One of two patients in whom mitochondrial rather than whole muscle DNA was analyzed had multiple populations of deleted mtDNA (dmtDNA). In all patients, the length of dmtDNA was inversely related to age of onset, but was not related to multiplicity of organ involvement. Patients with >50% dmtDNA tended to have an earlier onset of symptoms and a higher proportion of ragged-red fibers and cytochrome c oxidase (CCO)-negative fibers than patients with <50% dmtDNA, but these differences did not reach statistical significance. In some patients, CCO-negative fibers were more abundant than ragged-red fibers, indicating that the distribution of abnormal mitochondria can be more widespread than suggested by the frequency of ragged-red fibers. In biochemical assays, citrate synthase activity was a better reference for detecting defects in the respiratory complexes than the wet weight of muscle. Using this reference, 10 of 14 patients had one or more respiratory complex defects, and 74% of the observed defects could be correlated with an appropriate mtDNA deletion.

Address correspondence and reprint requests to Dr. Andrew G. Engel, Department of Neurology, Mayo Clinic, Rochester, MN 55905.

Supported by NIH grant NS 6277 and a grant from the Muscular Dystrophy Association. Dr. Clemens was the recipient of a Muscular Dystrophy Association postdoctoral fellowship.

Received March 21, 1991. Accepted for publication in final form May 6, 1991.

This article has been cited by other articles:

				K. Aure, H. Ogier de Baulny, P. Laforet, C. Jardel, B. Eymard, and A. Lombes Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Brain, June 1, 2007; 130(6): 1516 - 1524. [Abstract] [Full Text] [PDF]

				T. D. Jeppesen, M. Schwartz, A. L. Frederiksen, F. Wibrand, D. B. Olsen, and J. Vissing Muscle Phenotype and Mutation Load in 51 Persons With the 3243A>G Mitochondrial DNA Mutation Arch Neurol, December 1, 2006; 63(12): 1701 - 1706. [Abstract] [Full Text] [PDF]

				A. M. Remes, K. Majamaa-Voltti, M. Karppa, J. S. Moilanen, S. Uimonen, H. Helander, H. Rusanen, P. I. Salmela, M. Sorri, I. E. Hassinen, et al. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population Neurology, March 22, 2005; 64(6): 976 - 981. [Abstract] [Full Text] [PDF]

				P J Lamont, R Surtees, C E Woodward, J V Leonard, N W Wood, and A E Harding Clinical and laboratory findings in referrals for mitochondrial DNA analysis Arch. Dis. Child., July 1, 1998; 79(1): 22 - 27. [Abstract] [Full Text]